adenosine monophosphate has been researched along with Cardiac Toxicity in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, R; Ding, Q; Kwok, M; Lee, C; Leung, KT; Li, HS; Poon, EN; Tsang, SY; Tsoi, C; Yan, BP | 1 |
| Nabati, M; Parsaee, H | 1 |
1 review(s) available for adenosine monophosphate and Cardiac Toxicity
| Article | Year |
|---|---|
Potential Cardiotoxic Effects of Remdesivir on Cardiovascular System: A Literature Review.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Cardiotoxicity; Cardiovascular System; COVID-19 Drug Treatment; Humans | 2022 |
1 other study(ies) available for adenosine monophosphate and Cardiac Toxicity
| Article | Year |
|---|---|
Remdesivir induces persistent mitochondrial and structural damage in human induced pluripotent stem cell-derived cardiomyocytes.
Topics: Adenosine Monophosphate; Adenosine Triphosphate; Alanine; Animals; Cardiotoxicity; COVID-19 Drug Treatment; Humans; Induced Pluripotent Stem Cells; Myocytes, Cardiac; Nucleosides; Prodrugs | 2022 |